Prescription drug abuse: From epidemiology to public policy

Journal of Substance Abuse Treatment

Volumn 48, Issue 1, 2015, Pages 1-7

  McHugh, R Kathryn ^a,b   Nielsen, Suzanne ^c,d   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

Author keywords

Epidemiology; Nonmedical drug use; Prescription drug abuse; Prescription opioids; Treatment

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CANNABIS; DIAMORPHINE; ILLICIT DRUG; OPIATE; PRESCRIPTION DRUG; TRANQUILIZER;

ARTICLE; BEHAVIOR THERAPY; DRUG MISUSE; HUMAN; LIFESPAN; OPIATE ADDICTION; POLICY; PRIORITY JOURNAL; SEX DIFFERENCE; SUBSTANCE USE; TREATMENT RESPONSE; STATISTICS AND NUMERICAL DATA;

HUMANS; PRESCRIPTION DRUG MISUSE; PUBLIC POLICY;

EID: 84922773516     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.08.004     Document Type: Article

References (88)

1. Back S.E., Payne R.L., Simpson A.N., Brady K.T. Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addictive Behaviors 2010, 35:1001-1007. 10.1016/j.addbeh.2010.06.018.
2. Barth K.S., Maria M.M., Lawson K., Shaftman S., Brady K.T., Back S.E. Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence. The American Journal on Addictions 2013, 22:486-491. 10.1111/j.1521-0391.2013.12038.x.
3. Berenson A.B., Rahman M. Prevalence and correlates of prescription drug misuse among young, low-income women receiving public healthcare. Journal of Addictive Diseases 2011, 30:203-215. 10.1080/10550887.2011.581984.
4. Boyd C.J., McCabe S.E., Cranford J.A., Young A. Adolescents' motivations to abuse prescription medications. Pediatrics 2006, 118:2472-2480. 10.1542/peds.2006-1644.
5. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence 2004, 73:199-207.
6. Butler S.F., Budman S.H., Fernandez K., Jamison R.N. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004, 112:65-75. 10.1016/j.pain.2004.07.026.
7. Calcaterra S., Glanz J., Binswanger I.A. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug and Alcohol Dependence 2013, 131:263-270. 10.1016/j.drugalcdep.2012.11.018.
8. Chen K.W., Berger C.C., Forde D.P., D'Adamo C., Weintraub E., Gandhi D. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry 2011, 11:90. 10.1186/1471-244x-11-90.
9. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence 2006, 83(Suppl. 1):S4-S7. 10.1016/j.drugalcdep.2005.10.020.
10. Cranford J.A., McCabe S.E., Boyd C.J. Adolescents' nonmedical use and excessive medical use of prescription medications and the identification of substance use subgroups. Addictive Behaviors 2013, 38:2768-2771. 10.1016/j.addbeh.2013.06.015.
11. Dengenhardt L., Larance B., Mathers B., Azim T., Kamarulzaman A., Mattick R., et al. Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. Prepared on behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use 2008, National Drug and Alcohol Research Centre, University of New South Wales, Syndney, Australia.
12. Drazdowski T.K., Jaggi L., Borre A., Kliewer W.L. Use of prescription drugs and future delinquency among adolescent offenders. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.008.
13. Dreifuss J.A., Griffin M.L., Frost K., Fitzmaurice G.M., Potter J.S., Fiellin D.A., et al. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug and Alcohol Dependence 2013, 131:112-118. 10.1016/j.drugalcdep.2012.12.010.
14. Edwards R.R., Wasan A.D., Michna E., Greenbaum S., Ross E., Jamison R.N. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. Journal of Pain 2011, 12:953-963. 10.1016/j.jpain.2011.02.357.
15. Faraone S.V., Wilens T.E. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. Journal of Clinical Psychiatry 2007, 68(Suppl. 11):15-22.
16. Fleary S.A., Heffer R.W., McKyer E.L. Understanding nonprescription and prescription drug misuse in late adolescence/young adulthood. Journal of Addiction 2013, 2013:709207. 10.1155/2013/709207.
17. Green T.C., Grimes Serrano J.M., Licari A., Budman S.H., Butler S.F. Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug and Alcohol Dependence 2009, 103:65-73. 10.1016/j.drugalcdep.2009.03.014.
18. Havens J.R., Young A.M., Havens C.E. Nonmedical prescription drug use in a nationally representative sample of adolescents: Evidence of greater use among rural adolescents. Archives of Pediatrics & Adolescent Medicine 2011, 165:250-255. 10.1001/archpediatrics.2010.217.
19. Hilario E.Y., Griffin M.L., McHugh R.K., McDermott K.A., Connery H.S., Fitzmaurice G.M., et al. Denial of urinalysis-confirmed opioid use in prescription opioid dependence. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.003.
20. Holmes C.P., Gatchel R.J., Adams L.L., Stowell A.W., Hatten A., Noe C., et al. An opioid screening instrument: Long-term evaluation of the utility of the Pain Medication Questionnaire. Pain Practice 2006, 6:74-88. 10.1111/j.1533-2500.2006.00067.x.
21. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2006, 67:1062-1073.
22. Jamison R.N., Ross E.L., Michna E., Chen L.Q., Holcomb C., Wasan A.D. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A randomized trial. Pain 2010, 150:390-400. 10.1016/j.pain.2010.02.033.
23. Johnston L.D., O'Malley P.M., Bachman J.G., Schulnberg J.E. Monitoring the Future national survey results on drug use, 195-2006. Volume II: College students and adults ages 19-45. NIH Publication 07-6206 2007, National Institute on Drug Abuse, Bethesda, MD.
24. Johnston L.D., O'Malley P.M., Backman J.G., Schulenberg J.E. Monitoring the future national survey results on drug use, 1975-2012: Volume 2, college students and adults ages 19-50 2013, Institute for Social Research, The University of Michigan, Ann Arbor, MI.
25. Jones C.M. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug and Alcohol Dependence 2013, 132:95-100. 10.1016/j.drugalcdep.2013.01.007.
26. Katz C., El-Gabalawy R., Keyes K.M., Martins S.S., Sareen J. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: Results from a longitudinal nationally representative sample. Drug and Alcohol Dependence 2013, 132:107-113. 10.1016/j.drugalcdep.2013.01.010.
27. Kelly B.C., Rendina H.J., Vuolo M., Wells B.E., Parsons J.T. Influences of motivational contexts on prescription drug misuse and related drug problems. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.005.
28. Kollins S.H., Schoenfelder E.N., English J.S., Holdaway A., Van Voorhees R., O'Brien B.R. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.014.
29. Ling W., Hillhouse M., Domier C., Doraimani G., Hunter J., Thomas C., et al. Buprenorphine tapering schedule and illicit opioid use. Addiction 2009, 104:256-265. 10.1111/j.1360-0443.2008.02455.x.
30. Malekshahi T., Tioleco N., Ahmed N., Campbell A., Haller D. Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. Journal of Substance Abuse Treatment 2014.
31. Martel M.O., Wasan A.D., Jamison R.N., Edwards R.R. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug and Alcohol Dependence 2013, 132:335-341. 10.1016/j.drugalcdep.2013.02.034.
32. Martin C.E., Longinaker N., Terplan M. Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.007.
33. Martins S.S., Fenton M.C., Keyes K.M., Blanco C., Zhu H., Storr C.L. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine 2012, 42:1261-1272. 10.1017/s0033291711002145.
34. Martins S.S., Keyes K.M., Storr C.L., Zhu H., Chilcoat H.D. Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence 2009, 103:16-24. 10.1016/j.drugalcdep.2009.01.019.
35. Mateu-Gelabert P., Guarino H., Jessell L., Teper A. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.002.
36. Mazer-Amirshahi M., Mullins P.M., Rasooly I., van den Anker J., Pines J.M. Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010. Academic Emergency Medicine 2014, 21:236-243. 10.1111/acem.12328.
37. Mazer-Amirshahi M., Mullins P.M., Rasooly I.R., van den Anker J., Pines J.M. Trends in prescription opioid use in pediatric emergency department patients. Pediatric Emergency Care 2014, 30:230-235. 10.1097/pec.0000000000000102.
38. McCabe S.E., Boyd C.J., Teter C.J. Illicit use of opioid analgesics by high school seniors. Journal of Substance Abuse Treatment 2005, 28:225-230. 10.1016/j.jsat.2004.12.009.
39. McCabe S.E., Boyd C.J., Teter C.J. Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence 2009, 102:63-70. 10.1016/j.drugalcdep.2009.01.007.
40. McCabe S.E., Cranford J.A. Motivational subtypes of nonmedical use of prescription medications: Results from a national study. The Journal of Adolescent Health 2012, 51:445-452. 10.1016/j.jadohealth.2012.02.004.
41. McCabe S.E., Cranford J.A., West B.T. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addictive Behaviors 2008, 33:1297-1305. 10.1016/j.addbeh.2008.06.005.
42. McCabe S.E., West B.T. Medical and nonmedical use of prescription stimulants: Results from a national multicohort study. Journal of the American Academy of Child and Adolescent Psychiatry 2013, 52:1272-1280. 10.1016/j.jaac.2013.09.005.
43. McCabe S.E., West B.T. Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors. Addictive Behaviors 2014, 39:959-964. 10.1016/j.addbeh.2014.01.009.
44. McCabe S.E., West B.T., Morales M., Cranford J.A., Boyd C.J. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007, 102:1920-1930. 10.1111/j.1360-0443.2007.02015.x.
45. McCabe S.E., West B.T., Teter C.J., Boyd C.J. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Archives of Pediatrics & Adolescent Medicine 2012, 166:797-802. 10.1001/archpediatrics.2012.85.
46. McCabe S.E., West B.T., Teter C.J., Boyd C.J. Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors 2014, 39:1176-1182. 10.1016/j.addbeh.2014.03.008.
47. McCarty D., Bovett R., Burns T., Cushing J., Glynn M.E., Kruse S.J., et al. Oregon's strategy to confront prescription opioid misuse: A case study. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.012.
48. McCauley J.L., Amstadter A.B., Danielson C.K., Ruggiero K.J., Kilpatrick D.G., Resnick H.S. Mental health and rape history in relation to non-medical use of prescription drugs in a national sample of women. Addictive Behaviors 2009, 34:641-648. 10.1016/j.addbeh.2009.03.026.
49. McCauley J.L., Danielson C.K., Amstadter A.B., Ruggiero K.J., Resnick H.S., Hanson R.F., et al. The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2010, 51(1):84-93. 10.1111/j.1469-7610.2009.02134.x.
50. McHugh R.K., Devito E.E., Dodd D., Carroll K.M., Potter J.S., Greenfield S.F., et al. Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment 2013, 45:38-43. 10.1016/j.jsat.2012.12.007.
51. McHugh R.K., Park S., Weiss R.D. Cue-induced craving in dependence upon prescription opioids and heroin. The American journal on addictions/American Academy of Psychiatrists in Alcoholism and Addictions 2014, 10.1111/j.1521-0391.2014.12129.x.
52. Morasco B.J., Turk D.C., Donovan D.M., Dobscha S.K. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug and Alcohol Dependence 2013, 127:193-199. 10.1016/j.drugalcdep.2012.06.032.
53. Newville H., Roley J., Sorensen J.L. Prescription medication misuse among HIV-positive individudals taking antiretroviral therapy. Journal of Substance Abuse Treatment 2014.
54. Nielsen S., Bruno R., Lintzeris N., Fischer J., Carruthers S., Stoove M. Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?. Drug and Alcohol Review 2011, 30:291-299. 10.1111/j.1465-3362.2011.00302.x.
55. Nielsen S., Hillhouse M., Mooney L., Ang A., Ling W. Buprenorphine pharmacotherapy and behavioral treatment: Comparison of outcomes among prescription opioid users, heroin users and combination users. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.06.006.
56. Nielsen S., Hillhouse M., Mooney L., Fahey J., Ling W. Comparing buprenorphine induction experience with heroin and prescription opioid users. Journal of Substance Abuse Treatment 2012, 43:285-290.
57. Nielsen S., Hillhouse M., Thomas C., Hasson A., Ling W. A comparison of buprenorphine taper outcomes between prescription opioid and heroin users. Journal of Addiction Medicine 2013, 7:33-38. 10.1097/ADM.0b013e318277e92e.
58. Olfson M., Wang S., Iza M., Crystal S., Blanco C. National trends in the office-based prescription of schedule II opioids. The Journal of Clinical Psychiatry 2013, 74:932-939. 10.4088/JCP.13m08349.
59. Oser C.B., Harp K.L. Treatment outcomes for prescription drug misusers: The negative effect of client residence and treatment location geographic discordance. Journal of Substance Abuse Treatment 2014.
60. Parsells Kelly J., Cook S.F., Kaufman D.W., Anderson T., Rosenberg L., Mitchell A.A. Prevalence and characteristics of opioid use in the US adult population. Pain 2008, 138:507-513. 10.1016/j.pain.2008.01.027.
61. Paulozzi L.J., Mack K.A., Hockenberry J.M. Vital signs: Variation among states in prescribing opioid pain relievers and benzodiazepines. Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention 2014, 63:563-568.
62. Potter J.S., Marino E.N., Hillhouse M.P., Nielsen S., Wiest K., Canamar C.P., et al. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from starting treatment with agonist replacement therapies (START). Journal of Studies on Alcohol and Drugs 2013, 74:605-613.
63. Potter J.S., Dreifuss J.A., Marino E.N., Provost S.E., Dodd D.R., Rice L.S., et al. The multi-site Prescription Opioid Addiction Treatment Study: 18-Month outcomes. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.009.
64. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: Connecting the dots. Addiction 2007, 102:740-751.
65. Rabiner D.L., Anastopoulos A.D., Costello E.J., Hoyle R.H., McCabe S.E., Swartzwelder H.S. The misuse and diversion of prescribed ADHD medications by college students. Journal of Attention Disorders 2009, 13:144-153. 10.1177/1087054708320414.
66. Shannon L.M., Havens J.R., Hays L. Examining differences in substance use among rural and urban pregnant women. The American Journal on Addictions 2010, 19:467-473. 10.1111/j.1521-0391.2010.00079.x.
67. Shield K.D., Jones W., Rehm J., Fischer B. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009. Pain Research & Management 2013, 18:69-74.
68. Sigmon S.C., Dunn K.E., Saulsgiver K., Patrick M.E., Badger G.J., Heil S.H., et al. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry 2013, 70:1347-1354. 10.1001/jamapsychiatry.2013.2216.
69. Simoni-Wastila L., Yang H.K. Psychoactive drug abuse in older adults. The American Journal of Geriatric Pharmacotherapy 2006, 4:380-394. 10.1016/j.amjopharm.2006.10.002.
70. Stein M.D., Anderson B.J., Thurmond P., Bailey G.L. Comparing the life concerns of prescription opioid and heroin users. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.07.001.
71. Substance Abuse and Mental Health Services Administration Preliminary results from the 1997 National Household Survey on Drug Abuse. DHHS Pub. No. (SMA) 98-3200 1998, Substance Abuse and Mental Health Services Administration, Rockville, MD.
72. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Detailed tables Retrieved from. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/DetTabs/NSDUH-DetTabsTOC2012.htm.
73. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795 2013, (Rockville, MD).
74. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality Treatment Episode Data Set (TEDS): 2001-2011. State admissions to substance abuse treatment services. BHSIS Series S-68, HHS Publication No. (SMA) 14-4832 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
75. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality Treatment Episode Data Set (TEDS): 200-2012. National admissions to substance abuse treatment services. BHSIS Series S-71, HHS Publication No. (SMA) 14-4850 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
76. Sweeney C.T., Sembower M.A., Ertischek M.D., Shiffman S., Schnoll S.H. Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse. Journal of Addictive Diseases 2013, 32:1-10. 10.1080/10550887.2012.759858.
77. Tetrault J.M., Desai R.A., Becker W.C., Fiellin D.A., Concato J., Sullivan L.E. Gender and non-medical use of prescription opioids: Results from a national US survey. Addiction 2008, 103:258-268. 10.1111/j.1360-0443.2007.02056.x.
78. Voyer P., Preville M., Cohen D., Berbiche D., Beland S.G. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Canadian Journal on Aging 2010, 29:205-213. 10.1017/s0714980810000115.
79. Wang K.H., Becker W.C., Fiellin D.A. Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents. Drug and Alcohol Dependence 2013, 127:156-162. 10.1016/j.drugalcdep.2012.06.027.
80. Wasan A.D., Butler S.F., Budman S.H., Benoit C., Fernandez K., Jamison R.N. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. The Clinical Journal of Pain 2007, 23:307-315. 10.1097/AJP.0b013e3180330dc5.
81. Wasan A.D., Butler S.F., Budman S.H., Fernandez K., Weiss R.D., Greenfield S.F., et al. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?. The Clinical Journal of Pain 2009, 25:193-198. 10.1097/AJP.0b013e318193a6c4.
82. Weiss R.D., Potter J.S., Fiellin D.A., Byrne M., Connery H.S., Dickinson W., et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 2011, 68:1238-1246. 10.1001/archgenpsychiatry.2011.121.
83. Weiss R.D., Potter J.S., Griffin M.L., McHugh R.K., Haller D., Jacobs P., et al. Reasons for opioid use among patients with dependence on prescription opioids: The role of chronic pain. Journal of Substance Abuse Treatment 2014, 47:140-145. 10.1016/j.jsat.2014.03.004.
84. Whiteside L.K., Cunningham R.M., Bonar E.E., Blow F., Ehrlich P., Walton M.A. Nonmedical prescription stimulant use among youth in the emergency department: Prevalence, severity and correlates. Journal of Substance Abuse Treatment 2014, 10.1016/j.jsat.2014.05.003.
85. Whiteside L.K., Walton M.A., Bohnert A.S., Blow F.C., Bonar E.E., Ehrlich P., et al. Nonmedical prescription opioid and sedative use among adolescents in the emergency department. Pediatrics 2013, 132:825-832. 10.1542/peds.2013-0721.
86. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., et al. Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:21-31. 10.1097/chi.0b013e31815a56f1.
87. Wu L.T., Woody G.E., Yang C., Blazer D.G. Subtypes of nonmedical opioid users: Results from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence 2010, 112:69-80. 10.1016/j.drugalcdep.2010.05.013.
88. Wu L.T., Woody G.E., Yang C., Blazer D.G. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine 2011, 5:28-35. 10.1097/ADM.0b013e3181e0364e.